TIP
RPRX icon

Torray Investment Partners’s Royalty Pharma RPRX Stock Holding History

Torray Investment Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.8M Sell
602,028
-43,397
-7% -$2.26M 4.55% 2
2026
Q1 		$31M Sell
645,425
-98,930
-13% -$4.33M 4.54% 1
2025
Q4 		$28.8M Buy
744,355
+41,472
+6% +$1.58M 4.12% 2
2025
Q3 		$24.8M Buy
702,883
+14,107
+2% +$511K 3.36% 3
2025
Q2 		$24.8M Sell
688,776
-173,242
-20% -$5.74M 3.6% 3
2025
Q1 		$26.8M Buy
862,018
+178,011
+26% +$5.64M 4% 1
2024
Q4 		$17.4M Sell
684,007
-173,912
-20% -$4.61M 2.5% 9
2024
Q3 		$24.3M Buy
857,919
+164,361
+24% +$4.55M 3.4% 4
2024
Q2 		$18.3M Buy
693,558
+23,498
+4% +$651K 2.73% 5
2024
Q1 		$20.3M Buy
670,060
+164,320
+32% +$4.84M 3.05% 4
2023
Q4 		$14.2M Buy
505,740
+93,107
+23% +$2.56M 2.3% 13
2023
Q3 		$11.2M Sell
412,633
-1,182
-0.3% -$35.1K 1.98% 20
2023
Q2 		$12.7M Buy
413,815
+276,643
+202% +$9.37M 2.2% 16
2023
Q1 		$4.94M Sell
137,172
-199
-0.1% -$7.38K 0.89% 44
2022
Q4 		$5.43M Sell
137,371
-1,653
-1% -$69K 0.98% 37
2022
Q3 		$5.59M Buy
139,024
+12
+0% +$513 1.11% 33
2022
Q2 		$5.84M Buy
139,012
+6,942
+5% +$285K 1.11% 34
2022
Q1 		$5.14M Sell
132,070
-5,871
-4% -$231K 0.83% 45
2021
Q4 		$5.5M Buy
+137,941
New +$5.36M 0.81% 51

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Torray Investment Partners's RPRX Position: Q2 2026 in Review

Torray Investment Partners reduced its Royalty Pharma (RPRX) stake by 6.7% in Q2 2026, selling an estimated $2.26M and leaving 602,028 shares worth $33.8M. The position accounts for 4.55% of the portfolio, ranked #2.

Torray Investment Partners first reported a position in RPRX in Q4 2021 and has held it in 19 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Torray Investment Partners held 602,028 shares of Royalty Pharma worth $33.8M as of Q2 2026.
  • Torray Investment Partners sold 43,397 Royalty Pharma shares in Q2 2026, an estimated $2.26M.
  • Royalty Pharma made up 4.55% of Torray Investment Partners's portfolio in Q2 2026, its #2 holding.
  • Torray Investment Partners first reported a position in Royalty Pharma in Q4 2021 and has held it in 19 quarters since.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Torray Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.